67 results
Page 2 of 4
424B5
nx6661dwyc52e 5n
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
9u1u8g9yj6pnly2x5s8f
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99
0p99tdg3eqw9wy1i2tb7
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
6-K
EX-99
flowx9cy5zdi3v 964
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
6-K
EX-99
oc1 aaqpj
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
6-K
EX-99
nmc0ivzr84osw0dc0bz
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
424B2
7gqo3xp1la vhh7an9
13 Jun 14
Prospectus for primary offering
12:00am
F-3
4zupkgat l1et16j
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
wtqvzz3
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
ga6v2bq3y9 qc
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
iscx zmgh922xqgf
17 Mar 14
BioLineRx Reports Year End 2013 Financial Results
12:00am
6-K
EX-1.1
5vfj9 ywwdsiymxx9wl5
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
t1vlhqvkajjld
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
tecr4
3 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
2hm2nkhwnalnf6bt7 37
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
kmnsif9scfq28 0z
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
efax4 0cmc9r2kyaypr6
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
424B5
bfbzvzf534 hwt
17 May 13
Prospectus supplement for primary offering
12:00am